Long term clinical outcomes of brachytherapy, bare-metal stenting, and drug-eluting stenting for de novo and in-stent restenosis lesions: Five year follow-up
Orhan Doğdu(Erciyes University), Emrullah Başar(Erciyes University), Özgür Günebakmaz(Erciyes University), Şaban Keleşoğlu(Erciyes University), Bahadır Şarlı(Erciyes University), Mikail Yarlıoğlueş(Erciyes University), Erol Tülümen, Mahmut Akpek, Mehmet Güngör Kaya(Erciyes University), Nihat Kalay(Erciyes University), İdris Ardıç(Erciyes University)
Cited by 2
Related Papers
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
|Journal of the American College of Cardiology|2006|715
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
|International Journal of Cardiology|2012|325
Protective Effects of Spironolactone Against Anthracycline-Induced Cardiomyopathy
|European Journal of Heart Failure|2014|259
Cardiovascular Effects of Carbon Monoxide Poisoning
|The American Journal of Cardiology|2006|141